Clinical Proteomics encompasses all aspects of translational proteomics. This includes quantitative and qualitative profiling of proteins and peptides that are present in clinical specimens like human tissues and body fluids. Special emphasis is placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. As an open access journal, Clinical Proteomics is committed to rapid scientific review and timely publication of submitted manuscripts. This is achieved by receiving, processing and publishing submissions online. As molecular medicine moves beyond genomics to proteomics, the goal becomes the characterization of the cellular circuitry and the understanding of the impact of disease and therapy on precision medicine. Clinical Proteomics provides a scholarly forum for novel scientific research in the field of translational proteomics. The journal is publishing manuscripts with significant scientific discoveries or observations related to human diseases, for example the discovery and analytical and preclinical validation of novel diagnostic or therapy related markers, the potential of protein profiles for the development of personalized medicine. This will include original research articles and reviews in proteomics and bioinformatics. Articles in the development and application of technologies, clinical studies, methodologies, and protocols are also welcome.